GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Easy Bio Inc (XKRX:353810) » Definitions » DeferredTaxAndRevenue

Easy Bio (XKRX:353810) DeferredTaxAndRevenue : ₩0 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Easy Bio DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Easy Bio's current deferred tax and revenue for the quarter that ended in Sep. 2024 was ₩0 Mil.

Easy Bio DeferredTaxAndRevenue Historical Data

The historical data trend for Easy Bio's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easy Bio DeferredTaxAndRevenue Chart

Easy Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - - -

Easy Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Easy Bio DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Easy Bio's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Easy Bio Business Description

Traded in Other Exchanges
N/A
Address
310, Gangnam-daero, 4th Floor, Gangnam-gu, Seoul, KOR, 06253
Easy Bio Inc is a bio-technology company. The company conducts research, manufactures and markets animal feed products in South Korea.

Easy Bio Headlines

No Headlines